Should cancer patients with incurable disease receive parenteral or enteral nutritional support?
- 28 February 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (3) , 279-282
- https://doi.org/10.1016/s0959-8049(97)10049-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Neuroendocrine Responses to Starvation and Weight LossNew England Journal of Medicine, 1997
- Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancerBritish Journal of Surgery, 1997
- Home parenteral nutrition in adults: a multicentre surveyin Europe in 1993Clinical Nutrition, 1996
- Characterization of a cancer cachectic factorNature, 1996
- Cytokines, the Acute-Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic CancerAnnals of Surgery, 1994
- Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study.Journal of Clinical Oncology, 1993
- Parenteral Nutrition in Patients Receiving Cancer ChemotherapyAnnals of Internal Medicine, 1989
- A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer.Journal of Clinical Oncology, 1987
- Prednisolone as an appetite stimulant in patients with cancer.BMJ, 1984
- Changes in body composition of cancer patients following combined nutritional supportNutrition and Cancer, 1982